Stocktoria
Cordyceps Sunshine Biotech Holdings Co., Ltd. RAJAF
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $1.2M at a -12.4% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Manufacturing · percentile among 1906 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.901 |
| Retained earnings / assets | -0.183 |
| EBIT / assets | -0.03 |
| Equity / liabilities | -0.103 |
Sector peers · similar-size Manufacturing companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| RAJAF | Cordyceps Sunshine Biotech Holdings Co., Ltd. | 4/9 | -6.82 | — | — |
| NPHC | NUTRA PHARMA CORP | 3/9 | — | — | — |
| PLSH | PANACEA LIFE SCIENCES HOLDINGS, INC. | 4/9 | -13.95 | — | — |
| NTRR | NEUTRA CORP. | 4/9 | — | — | — |
| FTLF | FITLIFE BRANDS, INC. | 3/9 | 1.99 | 51.6 | -75.3% |
| BON | Bon Natural Life Ltd | 4/9 | 4.25 | — | -21.7% |
| CHUC | Charlie's Holdings, Inc. | 3/9 | -1.35 | 13.2 | — |
FAQ
Is RAJAF financially healthy?
Cordyceps Sunshine Biotech Holdings Co., Ltd.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does RAJAF pay a dividend?
No, Cordyceps Sunshine Biotech Holdings Co., Ltd. does not currently pay a dividend.
How profitable is RAJAF?
In FY2025, Cordyceps Sunshine Biotech Holdings Co., Ltd. had a net margin of -12.4%.
Source: SEC EDGAR filings · CIK 0001885680 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.